Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,957 public trials 633 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

NCT02177695

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • University of Arizona Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
View all 566 locations
View Trial Details
Completed

Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer

NCT00981656

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Emory Crawford Long Hospital Atlanta, Georgia, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • St. Agnes Hospital Cancer Center Baltimore, Maryland, United States
  • Hudner Oncology Center at Saint Anne's Hospital - Fall River Fall River, Massachusetts, United States
View all 13 locations
View Trial Details
Completed

A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment

NCT02301117

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +15 more
Locations
  • Phoenix Clinical Site Phoenix, Arizona, United States
  • Duarte Clinical Site Duarte, California, United States
  • Santa Monica Clinical Site Santa Monica, California, United States
  • Gainesville Clinical Site Gainesville, Florida, United States
View all 14 locations
View Trial Details
Completed

Evaluating Sexual Function in Women Undergoing a Radical Cystectomy for Bladder Cancer

NCT05399004

Conditions
Bladder Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • Louisiana State University Lafayette, Louisiana, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View all 14 locations
View Trial Details
Completed

MK-3475/BCG in High Risk Superficial Bladder Cancer

NCT02324582

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Simmons Cancer Institute-SIU School of Medicine Springfield, Illinois, United States
  • Southern Illinois University School of Medicine Springfield, Illinois, United States
  • Henry Ford Health Systems Detroit, Michigan, United States
View Trial Details
Completed

Using Virtual Reality (VR) Models for Preoperative Planning

NCT03334344

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • John Wayne Cancer Institute at Providence St. John's Heath Center Santa Monica, California, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • University of North Carolina, Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Completed

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

NCT03693612

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +33 more
Locations
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions